Financial Results - Standalone (₹ in Lakhs)
Quarter Ended 30th June 2026 (Unaudited)
- Revenue from Operations: ₹32,284.28
- Total Income: ₹32,284.28
- Total Expenses: ₹28,877.29
- Profit Before Tax: ₹3,337.77
- Tax Expense: ₹72.09 (Current Tax)
- Net Profit After Tax: ₹3,265.68
- Earnings Per Share (Basic): ₹17.18 (not annualized)
- Total Comprehensive Income: ₹3,267.93
Comparative Performance
- Revenue Growth YoY: Increased from ₹28,017.18 (Q1 2025) to ₹32,284.28 (Q1 2026)
- Net Profit Growth YoY: Increased from ₹2,920.60 (Q1 2025) to ₹3,265.68 (Q1 2026)
- Previous Quarter (Q4 2025): Revenue ₹4,569.36, Net Profit ₹378.80
Financial Results - Consolidated (₹ in Lakhs)
Quarter Ended 30th June 2026 (Unaudited)
- Revenue from Operations: ₹32,840.42
- Total Income: ₹32,840.42
- Total Expenses: ₹29,425.87
- Profit Before Tax: ₹3,298.27
- Tax Expense: ₹72.09 (Current Tax)
- Net Profit After Tax: ₹3,226.18
- Earnings Per Share (Basic): ₹16.98 (not annualized)
- Total Comprehensive Income: ₹3,228.43
Comparative Performance
- Revenue Growth YoY: Increased from ₹28,370.01 (Q1 2025) to ₹32,840.42 (Q1 2026)
- Net Profit Growth YoY: Increased from ₹2,828.11 (Q1 2025) to ₹3,226.18 (Q1 2026)
Capital Structure
- Paid-up Equity Share Capital: ₹1,900.40 lakhs (Face Value ₹10 each)
- Standalone Reserves & Surplus (as of 31st March 2026): ₹67,036.62 lakhs
- Consolidated Reserves & Surplus (as of 31st March 2026): ₹66,145.48 lakhs
Annual General Meeting
- 33rd AGM Date: Thursday, 24th September 2026 at 11:00 AM
- Mode: Video conference/other audio-visual means
- Book closure and record date: To be intimated separately
Audit Qualifications
Auditors Gautam N Associates issued a qualified opinion noting:
- Short provision of schemes amounting to ₹900.00 lakhs pertaining to quarter ending June 2025 was considered and represented in the results of June 2025
- This adjustment was previously reported in the quarterly results of March 2026
Subsidiary Information
- Results include consolidation of Nath Bio-Genes (Central Asia) LLC, Uzbekistan (90% equity holding)
- The joint venture entity's financial statements were converted from local accounting principles to Ind AS
Segment Information
- The company operates in a single business segment: Seed Cultivation
- No segmental reporting provided due to single segment operations
Investor Complaints
- Received during the quarter: NIL
- Pending at quarter end: NIL
Meeting Details
- Board Meeting Date: 29th July 2026
- Commencement Time: 1:00 PM
- Conclusion Time: 4:00 PM
- Audit Committee Review Date: 28th July 2026